07/07/2025Published by Fondazione Gianni Bonadonna at 07/07/2025Categories Events UncategorizedAlectinib plus bevacizumab in ALK-rearranged non-small cell lung cancer
30/06/2025Published by Fondazione Gianni Bonadonna at 30/06/2025Categories Events UncategorizedNivolumab and low-dose ipilimumab in HER2-negative metastatic breast cancer
23/06/2025Published by Fondazione Gianni Bonadonna at 23/06/2025Categories Events UncategorizedNeoadjuvant trastuzumab rezetecan in HER2-positive breast cancer
16/06/2025Published by Fondazione Gianni Bonadonna at 16/06/2025Categories Events UncategorizedDurvalumab with or without tremelimumab in combination with chemotherapy in first-line metastatic non-small-cell lung cancer
09/06/2025Published by Fondazione Gianni Bonadonna at 09/06/2025Categories Events UncategorizedTrastuzumab rezetecan in advanced HER2-mutant non small-cell lung cancer
26/05/2025Published by Fondazione Gianni Bonadonna at 26/05/2025Categories Events UncategorizedA new edition for the international fellowships in honor of Gianni Bonadonna
19/05/2025Published by Fondazione Gianni Bonadonna at 19/05/2025Categories Events UncategorizedAfamitresgene autoleucel in advanced synovial sarcoma and myxoid round cell liposarcoma
12/05/2025Published by Fondazione Gianni Bonadonna at 12/05/2025Categories Events UncategorizedSacituzumab tirumotecan in metastatic triple-negative breast cancer
05/05/2025Published by Fondazione Gianni Bonadonna at 05/05/2025Categories Events UncategorizedRegorafenib plus avelumab in gastroenteropancreatic neuroendocrine neoplasms
